Evidence map›Paper›PMID 37404047›Full record

ArticlemBio2023

P Todd Benziger, Erik J Kopping, Patrick A McLaughlin, David G Thanassi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. TolC and EmrA1 contribute toJournal of bacteriology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

P Todd BenzigerDepartment of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University , Stony Brook, New York, USA.
Erik J KoppingDepartment of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University , Stony Brook, New York, USA.
Patrick A McLaughlinDepartment of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University , Stony Brook, New York, USA.
David G ThanassiDepartment of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University , Stony Brook, New York, USA.ORCID 0000-0002-9798-9040
Stony Brook School · US

Funding

MOLECULAR AND CELL BIOLOGY OF INFECTIOUS DISEASEST32AI007539 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI KONOPKA, JAMES B · 1998 to 2023
$3.6M
Modulation of Host Cell Responses by Francisella tularensisR01AI141633 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI THANASSI, DAVID G · 2019 to 2023
$2.7M
NIAID NIH HHS R01 AI141633NIAID NIH HHS T32 AI007539
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Francisella tularensisTularemiaAnimalsApoptosisIon ChannelsMacrophagesMiceMyeloid Differentiation Factor 88Signal TransductionToll-Like Receptor 2VirulenceIon ChannelsMyeloid Differentiation Factor 88Toll-Like Receptor 2apoptosisbacterial pathogenesisFrancisella tularensismacrophages

Identifiers

PMID37404047
PMCPMC10470500
OpenAlexW4383187477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.